Postoperative Pain Control With Lipossomic Extended Release Bupivacaine
Randomized trial of intraoperative intercostal block with bupivacaine with epinephrine compared to lipossomal extended release bupivacaine.
Checked against the public recordLast updated Jun 20, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Sponsor
- University of Tennessee
- Interventions being studied
- Drug: Bupivacaine liposome; Drug: Bupivacaine / Epinephrine
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: Patients who will be undergoing minimally invasive thoracic surgery * Patients who will be undergoing minimally invasive thoracic surgery Exclusion Criteria: * Open surgery * Chronic use of narcotics * Use of pregabalin or similar * Significant liver or kidney dysfunction
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Methodist University HospitalMemphis, Tennessee
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 20, 2018. Always confirm current availability with the study team.